510(k) K082118

XPERT HEMOSIL FACTOR II & FACTOR V ASSAY by Cepheid — Product Code NPQ

K082118 is an FDA 510(k) premarket notification submitted by Cepheid for the device "XPERT HEMOSIL FACTOR II & FACTOR V ASSAY". The FDA issued a decision of Substantially Equivalent on Sep 18, 2009. The device falls under product code NPQ (Test, Factor V Leiden Mutations, Genomic Dna Pcr), a Class II device regulated under 21 CFR 864.7280. Cepheid has 52 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Sep 18, 2009
Date Received
Jul 28, 2008
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Test, Factor V Leiden Mutations, Genomic Dna Pcr
Device Class
Class II
Regulation Number
864.7280
Review Panel
PA
Submission Type
510(k)

In vitro diagnostic test to detect the Factor V Leiden mutation in genomic DNA, as an aid to diagnosis in the evaluation of patients with suspected thrombophilia.

Need the full FDA record for Cepheid? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K082118. Report a data issue: hello@regdatalab.com.